Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615), covering 2020-07-31 to 2021-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting [Phase 3]